Synthesis and biological activity of 2-cyanoacrylamide derivatives tethered to imidazopyridine as TAK1 inhibitors

Seok Jong Kang1,2, Jung Wuk Lee1, Jiho Song1

  • 1College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea.

Insights

Transforming growth factor beta-activated kinase 1 (TAK1) inhibitors are crucial for cell survival and cancer therapy. Novel reversible imidazopyridine derivatives show potent TAK1 inhibition, offering a safer alternative to irreversible compounds.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Medicinal Chemistry

Background:

  • Transforming growth factor beta-activated kinase 1 (TAK1) is vital for cell survival, regulating key signaling pathways like NF-κB and MAPK.
  • TAK1 inhibitors can induce cancer cell apoptosis, but irreversible inhibitors pose risks due to non-specific reactions.
  • Reversible covalent inhibitors are explored as safer alternatives to irreversible ones.

Purpose of the Study:

  • To synthesize novel imidazopyridine derivatives as potential TAK1 inhibitors.
  • To investigate the reversible covalent binding capabilities of these derivatives.
  • To evaluate the efficacy of synthesized compounds in inhibiting TAK1 activity.

Main Methods:

  • Synthesis of imidazopyridine derivatives featuring a 2-cyanoacrylamide moiety for reversible covalent bonding.
  • Assay of TAK1 inhibitory activity using IC50 determination.
  • Assessment of reversible reaction with β-mercaptoethanol.

Main Results:

  • A specific derivative, 2-cyano-3-(6-methylpyridin-2-yl)acrylamide (13h), demonstrated potent TAK1 inhibition with an IC50 of 27 nM.
  • Compound 13h exhibited reversible binding with β-mercaptoethanol.
  • The results support the potential of 13h as a reversible covalent TAK1 inhibitor.

Conclusions:

  • Novel imidazopyridine derivatives with a 2-cyanoacrylamide group effectively inhibit TAK1.
  • Compound 13h represents a promising reversible covalent inhibitor of TAK1.
  • These findings suggest a potential therapeutic strategy for cancers by targeting TAK1 with reversible inhibitors.

Related Concept Videos

Preparation of Amides01:29

Preparation of Amides

Amides are synthesized by treating carboxylic acids with amines in the presence of dehydrating agents like dicyclohexylcarbodiimide (DCC).
The DCC-promoted synthesis of amides begins with the protonation of DCC by carboxylic acid. The protonation makes it a better acceptor. Next, the addition of carboxylate to the protonated carbodiimide gives a reactive acylating agent.
Subsequently, the amine acts as a nucleophile that attacks the acylating agent to form a tetrahedral intermediate. In the...
3.7K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
797
Amines to Amides: Acylation of Amines01:19

Amines to Amides: Acylation of Amines

Various carboxylic acid derivatives (such as acid chlorides, esters, and anhydrides) can be used for the acylation of amines to yield amides. The reaction requires two equivalents of amines. The first amine molecule functions as a nucleophile and attacks the carbonyl carbon to produce a tetrahedral intermediate. This is followed by the loss of the leaving group and restoration of the C=O bond.
Next, the second equivalent of amine serves as a Brønsted base and deprotonates the quaternary...
3.2K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.7K
Basicity of Heterocyclic Aromatic Amines01:25

Basicity of Heterocyclic Aromatic Amines

Heterocyclic amines, where the N atom is a part of an alicyclic system, are similar in basicity to alkylamines. Interestingly, the heterocyclic amine having a nitrogen atom as part of an aromatic ring has much less basicity than its corresponding alicyclic counterpart. For this reason, as presented in Figure 1, piperidine (pKb = 2.8) is significantly more basic than pyridine (pKb = 8.8).
6.7K